Kenneth Erland Johnson

Entity
Individual
Business address
C/O Xeris Pharmaceuticals, Inc., 180 N. Lasalle Street, Suite 1800, 60601 Chicago, IL
Signature Ownership
/s/ Beth Hecht, Attorney-in-Fact
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Kenneth Erland Johnson has filed 20 SEC EDGAR filings since 6/20/2018

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 Feb 3, 2025 Jan 31, 2025 001-40880
4 Open Document Open Filing FORM 4 Jan 7, 2025 Jan 3, 2025 001-40880
4 Open Document Open Filing FORM 4 Aug 9, 2024 Jan 29, 2022 001-40880
4 Open Document Open Filing FORM 4 Jan 31, 2024 Jan 31, 2024 001-40880
4 Open Document Open Filing FORM 4 Feb 1, 2023 Jan 31, 2023 001-40880
4 Open Document Open Filing FORM 4 Jan 5, 2022 Jan 3, 2022 001-40880
4 Open Document Open Filing FORM 4 SUBMISSION Oct 5, 2021 Oct 5, 2021 001-40880
4 Open Document Open Filing FORM 4 SUBMISSION Oct 5, 2021 Oct 5, 2021 001-38536
3 Open Document Open Filing FORM 3 Oct 5, 2021 Oct 5, 2021 001-40880
4 Open Document Open Filing FORM 4 Feb 1, 2021 Jan 29, 2021 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION Aug 17, 2020 Aug 14, 2020 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION Jul 15, 2020 Jun 30, 2020 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION Mar 2, 2020 Jan 31, 2020 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION Feb 18, 2020 Feb 14, 2020 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION Jan 6, 2020 Dec 31, 2019 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION Jul 3, 2019 Jul 1, 2019 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION Feb 25, 2019 Feb 19, 2019 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION Feb 1, 2019 Jan 31, 2019 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION Jun 27, 2018 Jun 25, 2018 001-38536
3 Open Document Open Filing FORM 3 SUBMISSION Jun 20, 2018 Jun 20, 2018 001-38536